Abstracts

IMPACT OF BASELINE FACTORS ON VIROLOGIC RESPONSE TO bNAb VH3810109 (N6LS) IN BANNER

Background: Broadly neutralizing antibodies (bNAbs) are being developed for long-acting HIV-1 therapy. VH3810109 (N6LS) is a CD4-bs antibody with broad and potent neutralization activity in vitro, which is currently being evaluated in the Phase 2a BANNER study. Methods: BANNER is a randomized, open-label, 2-part, multicenter study in treatment-naive viremic (viral load [VL] ≥5000 c/mL) adults…

EVALUATING THE USE OF DOSE-SPARING VACCINATION STRATEGIES FOR MPOX

Background: The 2022 monkeypox outbreak had over 80,000 cases globally with most of them in gay, bisexual, and other men who have sex with men (MSM). In response to vaccine shortages, several countries implemented dose-sparing vaccination strategies, stretching a full-dose vaccine vial in up to 5 fractional-dose vaccines. Recent studies have found mixed results regarding…

DAPIVIRINE RING SAFETY AND DRUG DETECTION IN BREASTFEEDING MOTHER-INFANT PAIRS

Background: Global guidance supports exclusive breastfeeding for infants up to six months of age, continued breastfeeding with the introduction of complementary foods. World Health Organization (WHO) guidance also supports provision of oral pre-exposure prophylaxis (PrEP) for breastfeeding people at substantial risk of HIV acquisition. In January 2021, WHO recommended the 25 mg dapivirine vaginal ring…

MODELED IMPACT OF HIV SELF-TESTING FOR PrEP SCALE-UP ON DRUG RESISTANCE IN KENYA

Background: Community-based oral pre-exposure prophylaxis (PrEP) provision has the potential to expand PrEP access. HIV self-testing (HIVST) can facilitate scale-up of PrEP delivery; however, HIVST can have lower field performance than standard provider-administered testing, potentially leading to inappropriate PrEP provision to persons with HIV and contributing to the development of drug resistance. The impact of…

EFFECT OF INTIMATE PARTNER VIOLENCE ON ART & PrEP ADHERENCE IN SERODIFFERENT COUPLES

Background: Experiences of intimate partner violence (IPV) are associated with reduced adherence to antiretroviral (ART) and pre-exposure prophylaxis (PrEP) nonadherence, increased risk of HIV acquisition and poorer engagement in HIV care. There is limited evidence describing the ways in which exposure to violence and other maladaptive relationship dynamics may influence ART and PrEP adherence for…